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Introduction : 
Due to the taboo associated with erectile dysfunction, phosphodiesterase type 5 
(PDE5) inhibitors are widely sold over the internet as both counterfeited medicines 
and illegal adulterants in herbal dietary supplements [1]. 
For this study, three analogues of sildenafil (acetildenafil, hydroxyacetildenafil and 
dimethylsildenafil), one of vardenafil (pseudovardenafil), one of tadalafil 
(aminotadalafil) and the bioactive diastereoisomer of tadalafil (trans-tadalafil) have 
been chosen. A full validation has been performed using the “total error” approach 
[2].
The method is also compatible with on-line coupling mass spectrometry and will 
significantly reduce analysis times and solvent consumption.
Chromatographic conditions : 
Validation : 
Conclusions : 
The method has been first developed on HPLC and then transferred to an Acquity
UPLC™ system with a diode array detector. The separation is performed on an 
Acquity™ BEH Shield RP18 (100mm x 2.1mm I.D., 1.7µm particle size) column. 
The final method is a gradient elution with pH3.5 formate ammonium buffer 
(10mM) as aqueous phase (solvent A) and acetonitrile as organic modifier 
(solvent B).
Injection volume: 1.5 µl
Temperature: 40°C
Detection UV: 285 nm
The compounds were divided in two groups according to their UV absorbance at 
285 nm.
Group 1 contains hydroxyacetildenafil, acetildenafil and tadalafil. The second 
group contains vardenafil, sildenafil, dimethylsildenafil, aminotadalafil and 
pseudovardenafil. 
All solutions were prepared in a mixture of H2O/ACN (50:50, v/v).
Linearity:
For each substance, a calibration line has been prepared. Calibration lines cover 
the concentration ranges of  3 – 32 µg/ml for group 1 and 9 – 96 µg/ml for group 
2. The calibration model was an unweighted linear regression. 
For all of the eight compounds the relationship was linear as the r² were all > 0.99 
and the equation was close to y = x.
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Trueness, precision, accuracy and uncertainty assessment : 
The presented fully validated method enables the detection and the quantification 
of authorised PDE5 inhibitors and some of their analogues in less than 4.5 
minutes. This rapidity associated to a low flow rate permits the analysis of a large 
number of samples with a reduced cost and associated solvent consumption. 
The method has already been applied to real samples and showed no interference 
with common other substances present as yohimbine (retention time of 0.77 min) 
and caffeine (retention time of 0.57 min).
The main problem with counterfeit medicines is that their chemical composition is 
unknown. This is why they represent a real danger for public health. The method 
permits the detection of all PDE5 inhibitors even new ones as it covers a wide 
range of polarity. The elucidation of structures and the confirmation of identity may 
be performed by UHPLC-MS systems since the mobile phase is compatible. 
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The samples stock solutions were prepared the same way as the reference 
standards with the addition of 200 mg herbal matrix to the pure substances. 
These solutions were magnetically stirred for 30 minutes, sonicated during 10 
minutes and diluted to obtain three concentration levels. 
These levels were chosen with a ratio 0.5/1/2 to cover a large concentration 
range and to take into account the differences in concentration of the approved 

















The concentrations were back-calculated using the calibration lines. These 
concentrations were used to determine the relative bias, the repeatability, the 
intermediate precision and the β-expectation tolerance intervals at the 95 % 
probability level. 
The RSD values of repeatability and intermediate precision are said acceptable 
since they are inferior to two-thirds of the Horwitz value [3] (1.76 % for sildenafil in 
Viagra®, 2.06 % for tadalafil in Cialis® and 1.86 % for vardenafil in Levitra®).
